Discovery of the selective and orally available galectin-1 inhibitor GB1908 as a potential treatment for lung cancer

FR Zetterberg, K Peterson, UJ Nilsson… - Journal of Medicinal …, 2024 - ACS Publications
We have previously described a new series of selective and orally available galectin-1
inhibitors resulting in the thiazole-containing glycomimetic GB1490. Here, we show that the …

Discovery of selective and orally available galectin-1 inhibitors

FR Zetterberg, C Diehl, M Håkansson… - Journal of Medicinal …, 2023 - ACS Publications
A new series of orally available α-d-galactopyranosides with high affinity and specificity
toward galectin-1 have been discovered. High affinity and specificity were achieved by …

Human galectin-1 in multiple cancers: a privileged molecular target in oncology

NS Goud, A Bhattacharya - Mini Reviews in Medicinal Chemistry, 2021 - benthamdirect.com
Galectin-1 (Gal-1), a 14kDa carbohydrate-binding protein of the galectin family found in
humans, affects intracellular signaling pathways upon interaction with β-galactosides on cell …

Mannosyl, glucosyl or galactosyl liposomes to improve resveratrol efficacy against Methicillin Resistant Staphylococcus aureus biofilm

S Aiello, L Pagano, F Ceccacci, B Simonis… - Colloids and Surfaces A …, 2021 - Elsevier
Novel cationic glycoliposomes, composed of 1, 2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC), cholesterol (Chol) and glycoamphiphiles featuring a galactosyl, mannosyl or …

Characterization of galectin fusion proteins with glycoprotein affinity columns and binding assays

C Dey, P Palm, L Elling - Molecules, 2023 - mdpi.com
Galectins are β-galactosyl-binding proteins that fulfill essential physiological functions. In the
biotechnological field, galectins are versatile tools, such as in the development of …

Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity

C Matteucci, R Nepravishta, A Argaw-Denboba… - International …, 2023 - Elsevier
The study of mechanism of action of Thymosin alpha 1 (Tα1) and the basis of the pleiotropic
effect in health and disease, is one of the main focus of our ongoing research. Tα1 is a …

A Quantitative Human Red Blood Cell Agglutination Assay for Characterisation of Galectin Inhibitors

R Gasson, JA Roper, RJ Slack - International Journal of Molecular …, 2024 - mdpi.com
Galectins are a family of beta-galactoside-binding proteins that are characterised by their
carbohydrate recognition domain (CRD) and include galectin-1 and galectin-3. These …

Pharmacological characterization of GB1908, a selective galectin-1 carbohydrate binding domain inhibitor for the treatment of cancer.

KD Herman, I Holyer, DC Humphries, JA Roper… - Pharmacology, 2025 - karger.com
Abstract Introduction: Galectin-1 (Gal-1) is a lectin that has been shown to be involved in a
number of pro-tumorigenic mechanisms and has also been shown to be immune …

[КНИГА][B] Elucidating the Role of Sialic Acid in Tumorigenic Pathways

K Das - 2024 - search.proquest.com
Hypersialylation is a prognostic biomarker in cancer cells. The upregulated sialic acid
expression on cancer cells facilitates tumorigenesis by playing a critical role in cancer cell …

Purification of galectin-1 mutants using an immobilized Galactoseβ1–4Fucose affinity adsorbent

T Takeuchi, M Tamura, N Ishii, H Ishikida… - Protein expression and …, 2015 - Elsevier
Galectins are a family of lectins characterized by their carbohydrate recognition domains
containing eight conserved amino acid residues, which allows the binding of galectin to β …